Professional Documents
Culture Documents
Equity that is not publicly traded. Common forms include Leveraged Buyouts
Products / Services (LBOs),Venture Capital (VC), Mezzanine Capital, Distressed Investments, and
Growth Capital
Return on investments, management fees. Levers pulled to increase revenue:
Revenue timeframe, identifying efficiencies, new management
Investment expenses, legal, technical assistance to firms, administrative expenses,
Costs travel, labor is very costly (few and highly paid employees), taxes
Competitive Landscape
Supply of capital greater than demand. Large (e.g. KKR, Carlyle, Blackstone, TPG),
(competitors, substitutes, Mid ($250M to $5B), and Small Market PE shops
new entrants)
New customers of PE deals may be corporations; institutional investor; customers
Customers can range from small family-owned companies to large corporations
Leveraged Buyouts: controlling interest (of equity) is acquired through high
borrowing.Venture Capital: investors give cash in exchange for shares/control;
typical with start-ups. Mezzanine Capital: financing that contains equity based
Distribution Channel(s) options and subordinated debt (e.g. convertible loans). Growth capital: financing to
expand, restructure, or enter new markets with little change in management.
Distressed Investments: investing in financially stressed companies
Suppliers / Supply Chain Private investors, large corporations, foundations
Larger amounts of equity required for each deal, startup financial performance not
always meeting high valuations. Health care and tech are seeing most of the
Key Trends activity. Buying and selling of current PE commitments likely to increase over the
next few years Growing need for PE firms to have cash margins
PHARMACEUTIC ALS
Brand name/originator drug manufacturers produce original patent-protected (for a certain period
of time) drugs for human and animal diseases. Generic drug producers produce ‘copy-cat’ drugs
Products / Services (with the same medical result) at a lower development cost when the originator drug’s patent
expires.
Size of specific treatment area / level of competition; Buy-in from doctors that will prescribe; Speed
to market (1st to market is important)/ expertise in difficult products (for generics). Dosage and
Revenue frequency of drugs can alter revenue. Revenue can come directly from patients, but most is received
from third party insurers)
VC: sales and marketing (doctor visits, sponsored studies); FC: R&D (drug discovery, formulation,
Costs clinical trials; a lot of this is now outsourced; generic companies only need to perform clinical trials
and are therefore fast to come to market once a patent expires)
Success contingent on drug effectiveness, adoption/buy-in from doctors, coverage approval from
Competitive Landscape private and public insurers, patient adherence and ease of use. Products compete within various
treatment areas (T): cancer, cardiovascular, psychology etc. US, Europe and Japan are largest
(competitors, substitutes, markets although emerging market opportunity (eg. China, India, Brazil) is growing. In the US, the
new entrants) Food & Drug Authority (FDA) needs to approve all drugs before sale. Generic drugs are treated as
substitutes and usually receive more favorable reimbursements by insurers.
Doctors who prescribe these medicines; insurance companies that pay for them (i.e. private
insurers, Medicare (over 65), Medicaid (low-income/disabled); patients/consumers who need these
Customers drugs/medicines. In some emerging markets officials (provincial and central government) may control
channel access
Over the counter (“OTC”, can be sold without prescription); Retail outlets – CVS, Walgreens; Mail
Distribution Channel(s) order/online; hospitals; pharmacies; doctor’s offices; B2B: Distributors/intermediaries
Price competition from generic drug manufacturers. Increasing pressure from health insurance
companies and hospitals to reduce prices. R&D challenge of finding high revenue drugs
Key Trends (‘Blockbusters’ have annual sales > $1B). Weaker investments in R&D in recent years. Loss of patent
on key drugs for many large pharma companies, especially specialty biologic drugs in next 5 years.
AIRLINE
Ticket sales, baggage fees, food and beverage sales, freight fees, new classes (Economy Plus as
Revenue
well as Economy “Basic”)
Fuel, food and beverage, ground crew, air crew, aircraft lease/payments, airport fees, IT/admin
Costs
fees, frequent flier program fees, marketing and sales, offices, hangars, INSURANCE.
Legacy carriers (Delta, United, American, Lufthansa, Air India, British Airways) compete with
Competitive Landscape each other and are also competing with low cost carriers (Southwest, Allegiant Air, Frontier
(competitors, substitutes, new Airlines, Eurowings, Gogo Air). New entrants are more common in the low cost model.
entrants) Barrier to entry include available gate space / airport leasing agreements and extremely high
startup costs.
Individual passengers, corporate travelers, travel agents/websites, freight/cargo shipping
Customers
companies.
Direct from the airline (website, at the airport, over the phone), travel agents (website, in
person, over the phone), through other providers as a bundle (cruise and flight bundle, hotel
Distribution Channel(s)
and flight bundle etc.), increasing number of tickets sold through trip aggregators (Kayak,
Priceline, etc)
Metrics: Available Seat Miles (Total # seats available for transporting) * (# miles flown in
a period), Revenue Passenger Mile (RPM) = (#Revenue-paying passengers)*(#miles
Key Trends
flown in a period), Revenue per Available Seat Mile = (Revenue) / (# seats available),
Load Factor -- % of available seating capacity which is actually filled with passengers
MEDIA
Media sector includes print, audio and video content generation and
Products / Services distribution.
Advertising is a key revenue driver, additional revenue sources are
Revenue subscriptions, one-time purchases (video on demand, DVD purchase), licensing
fees. For online portals (NetFlix, Hulu, etc.) the key value driver is content.
Production costs (salary, technology, location fees etc), distribution costs,
Costs marketing and advertising, promotions, capital costs (studios, equipment etc.)
Highly competitive with a few major players owning most of the market. Fight
Competitive Landscape over content exclusivity is a big issue among legacy players (Netflix, Hulu) and
(competitors, substitutes, content providers (Disney etc.). Traditional cable companies getting hurt by
new entrants) these web-based solutions.
Individual viewers are part of the product for most ad-revenue driven models.
Customers The main customers there are the advertising companies. For subscription
based models, the end viewer or consumer of the content is the customer.
Online streaming is the fastest growing channel, tradition distribution through
Distribution Channel(s) retail outlets still exists. Additional distribution through theaters and other ‘live’
events.
Technology providers (particularly internet service providers are becoming key
Suppliers / Supply Chain in allowing high speed streaming), actors, artists and musicians
Online streaming and cord cutting is changing the industry. There is a large
Key Trends focus on creating and controlling content. Companies such as Netflix and
Yahoo are starting to create original content to remain competitive
TECHNOLOGY
Competitive Landscape Few large competitors in PC and server space, many competitors in the software and
(competitors, substitutes, application development space. Internet companies have low barriers to entry so highly
competitive environment; acquisitions of smaller players are common by internet giants.
new entrants)
Varies by product: ranges from individual customers and corporations to companies looking
Customers for advertising channels. Internet companies tend to be B2C (ad click revenue), while
companies such as IBM, Oracle, Cisco focus on B2B.
Distribution thru retail outlets and B2B channels for hardware, online distribution through
Distribution Channel(s) app stores/websites for software. Limited distribution of software through physical media
For hardware: various suppliers include raw material providers, semiconductor manufactures,
machine and technology providers
Suppliers / Supply Chain For software: supply chain includes software testing houses, distribution through 3rd party
such as app store
Acquisition of talent and technology by established industry players. Freemium and ad-driven
revenue models for software. New technologies entering the business segment: Internet of
Key Trends Things, cloud computing, big data (predictive) analytics, mobile (computing everywhere), 3D
printing, machine learning.